Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine Tumors
Status:
Completed
Trial end date:
2021-06-29
Target enrollment:
Participant gender:
Summary
This study will evaluate the potential immunomodulatory synergy of the association of
metronomic cyclophosphamide (CMC) and interferon-alpha (IFN-alpha).